Warren Buffett's Berkshire Just Spent a Record $9.6 Billion Buying Its Own Stock

Berkshire Hathaway repurchased a record $9.6 billion of its stock in Q3 at an average price of $503.68; Class B shares later closed at $570.89. Quarterly operating earnings fell 5.8% to $12.7 billion as insurance results weakened, despite growth in railroad, energy and manufacturing businesses. The article estimates a retiree’s 500 shares are worth $285,445 and that selling about 20 shares annually could generate roughly $11,418 before an estimated $1,272 in federal tax.

Analysis

The buyback is best read as a capital-allocation signal, not a durable price floor. It supports confidence in the business and in Abel’s willingness to return capital when management sees value, but does not establish that the shares remain attractive after the market repriced them. Repurchases made at a lower price also create less incremental value for continuing holders if future buybacks occur at higher valuations; if the price rises above management’s estimate of intrinsic value, the policy itself implies repurchases should slow or stop.

The second-order exposure is earnings quality: weaker insurance underwriting and lower reinvestment yields on cash could offset strength in operating subsidiaries. A decline in rates is a mixed catalyst—less income on the cash portfolio, but potentially more attractive acquisition financing and lower discount rates. Over the next 1–3 months, watch for evidence that repurchases continued after the quarter and for insurance underwriting trends; over 6–18 months, the key test is whether Abel allocates excess cash at returns competitive with buybacks. The headline risks encouraging investors to extrapolate one quarter’s authorization into a standing bid. The retiree-style share-sale framing is not a corporate catalyst and does not remove sequence-of-returns risk.

No valuation or post-quarter repurchase data are provided, so a fresh long recommendation or price target is not justified. The buyback thesis weakens if underwriting deterioration persists, cash yields fall faster than operating earnings grow, or management stops repurchasing while the stock remains expensive relative to verified intrinsic-value estimates.

Key Decisions for Investors

• Do not chase BRK.A solely on the repurchase disclosure. Treat the buyback as a conditional signal; verify post-quarter repurchase activity and compare it with the share price before assigning it ongoing support.
• For a relative-value position, consider long BRK.A versus SPY only if updated valuation work shows a sufficient discount and total-return comparisons include SPY distributions. Without that work, keep the pair on watch rather than initiating it.
• Track insurance underwriting results, cash-portfolio income and share-count changes over the next two reports. Persistent underwriting weakness or continued dilution of cash returns without productive redeployment would falsify the improving capital-allocation case.
• For income-oriented holders, distinguish selling shares from receiving a dividend: a planned draw still entails selling into weak markets. Evaluate liquidity needs and sequence risk separately from the buyback signal.